Clinical Trial Update: [KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2b/3 clinical trial update for KSR-001 in dry eye syndrome completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• KSR-001

Snippet

Sponsor: Kukje Pharma | Conditions: Dry Eye Syndromes | Phase 2, Phase 3 | Status: COMPLETED